FDA
-
-
-
-
-
-
-
Dianthus Therapeutics advances Phase 3 CIDP trial early
-
-
-
-
-
-
-
Dianthus reports positive phase 2 trial results for myasthenia gravis drug
-
-
-
-
-
-
-
Dianthus Therapeutics (DNTH) Granted FDA Clearance to Initiate Phase 2 Trial of DNTH103
-
-
329,957 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

